Han‐Tsang Wu

636 total citations
16 papers, 479 citations indexed

About

Han‐Tsang Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Han‐Tsang Wu has authored 16 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Han‐Tsang Wu's work include Ubiquitin and proteasome pathways (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (4 papers). Han‐Tsang Wu is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (4 papers). Han‐Tsang Wu collaborates with scholars based in Taiwan, Malaysia and Canada. Han‐Tsang Wu's co-authors include Kou‐Juey Wu, Shih-Han Kao, Kai‐Wen Hsu, Dar‐Ren Chen, Joseph Lin, Yeh Chen, Wei‐Chung Cheng, Yu‐Ju Chen, Chang‐Chi Hsieh and Hsiao‐Fan Chen and has published in prestigious journals such as Nature Communications, Cancer Research and Fertility and Sterility.

In The Last Decade

Han‐Tsang Wu

14 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han‐Tsang Wu Taiwan	8	349	132	119	47	46	16	479
Sung‐Eun Hong South Korea	14	301 0.9×	86 0.7×	61 0.5×	42 0.9×	45 1.0×	27	467
Robert Kleszcz Poland	15	356 1.0×	119 0.9×	94 0.8×	18 0.4×	37 0.8×	39	590
Luoqi Jia China	9	282 0.8×	120 0.9×	123 1.0×	26 0.6×	36 0.8×	13	452
Ravi Manoharan India	15	314 0.9×	102 0.8×	76 0.6×	29 0.6×	31 0.7×	26	448
Xundi Xu China	13	424 1.2×	206 1.6×	130 1.1×	21 0.4×	58 1.3×	31	718
Uma Chandran India	9	347 1.0×	273 2.1×	184 1.5×	41 0.9×	37 0.8×	11	718
Aijing Sun China	13	387 1.1×	78 0.6×	75 0.6×	44 0.9×	88 1.9×	34	613
Addanki P. Kumar United States	9	265 0.8×	87 0.7×	69 0.6×	27 0.6×	49 1.1×	10	432
Ma'in Y. Maitah United States	8	397 1.1×	91 0.7×	125 1.1×	17 0.4×	41 0.9×	11	485

Countries citing papers authored by Han‐Tsang Wu

Since Specialization

Citations

This map shows the geographic impact of Han‐Tsang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Tsang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Tsang Wu more than expected).

Fields of papers citing papers by Han‐Tsang Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Tsang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Tsang Wu. The network helps show where Han‐Tsang Wu may publish in the future.

Co-authorship network of co-authors of Han‐Tsang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Tsang Wu. A scholar is included among the top collaborators of Han‐Tsang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Tsang Wu. Han‐Tsang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lin, Joseph, Yueh‐Te Lin, Kai‐Wen Hsu, et al.. (2025). Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression. Cancer Cell International. 25(1). 60–60. 1 indexed citations

Chen, Ji‐Lin, Pei‐Hua Peng, Han‐Tsang Wu, et al.. (2024). ALKBH4 functions as a hypoxia-responsive tumor suppressor and inhibits metastasis and tumorigenesis. Cellular Oncology. 48(2). 425–435.

Peng, Pei‐Hua, Ji‐Lin Chen, Heng‐Hsiung Wu, et al.. (2023). Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis. Cancer Cell International. 23(1). 266–266. 3 indexed citations

Shao, I‐Hung, Pei‐Hua Peng, Heng‐Hsiung Wu, et al.. (2023). RP11‐367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial–mesenchymal transition. Cancer Medicine. 12(8). 9788–9801. 7 indexed citations

Lin, Yueh‐Te, et al.. (2022). USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1. Cells. 11(20). 3294–3294. 23 indexed citations

Wu, Han‐Tsang, Yueh‐Te Lin, Shan Hwu Chew, & Kou‐Juey Wu. (2022). Organ defects of the Usp7 mutant mouse strain indicate the essential role of K63-polyubiquitinated Usp7 in organ formation. Biomedical Journal. 46(1). 122–133. 2 indexed citations

Lin, Yueh‐Te, Joseph Lin, Kai‐Wen Hsu, et al.. (2021). Nafamostat mesylate overcomes endocrine resistance of breast cancer through epigenetic regulation of CDK4 and CDK6 expression. Translational Oncology. 15(1). 101302–101302. 7 indexed citations

Wu, Han‐Tsang, Joseph Lin, Hsiao‐Fan Chen, et al.. (2020). Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway. Phytomedicine. 81. 153437–153437. 123 indexed citations

Wu, Han‐Tsang, et al.. (2020). MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway. The American Journal of Chinese Medicine. 48(5). 1221–1241. 52 indexed citations

10.

Kao, Shih-Han, Wei‐Chung Cheng, Yi‐Ting Wang, et al.. (2019). Regulation of miRNA Biogenesis and Histone Modification by K63-Polyubiquitinated DDX17 Controls Cancer Stem-like Features. Cancer Research. 79(10). 2549–2563. 50 indexed citations

11.

Kao, Shih-Han, Han‐Tsang Wu, & Kou‐Juey Wu. (2018). Ubiquitination by HUWE1 in tumorigenesis and beyond. Journal of Biomedical Science. 25(1). 67–67. 80 indexed citations

12.

Wu, Han‐Tsang, Wei‐Yi Chen, Teh‐Ying Chou, et al.. (2016). K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression. Nature Communications. 7(1). 13644–13644. 102 indexed citations

13.

Wu, Han‐Tsang, et al.. (2015). Nijmegen breakage syndrome protein 1 (NBS1) modulates hypoxia inducible factor-1α (HIF-1α) stability and promotes in vitro migration and invasion under ionizing radiation. The International Journal of Biochemistry & Cell Biology. 64. 229–238. 10 indexed citations

14.

Wu, Han‐Tsang, Yi‐Ning Su, Chia‐Cheng Hung, Wu‐Shiun Hsieh, & Kou‐Juey Wu. (2009). Interaction between PHOX2B and CREBBP mediates synergistic activation: Mechanistic implications of PHOX2B mutants. Human Mutation. 30(4). 655–660. 18 indexed citations

15.

Wu, Han‐Tsang, et al.. (2005). Comparison of the Ovulation Induction and Hormone Profile Between Anastrozole and Clomiphene Citrate in Women With Infertility. Fertility and Sterility. 84. S324–S324. 1 indexed citations

16.

Gonda, Steve R., et al.. (1999). Three-Dimensional, Transgenic Cell Models to Quantify Space Genotoxic Effects. NASA Technical Reports Server (NASA).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact